Bath & Body Works, Inc. (BBWI)
Bath & Body Works disclosed unaudited financial results for Q1 2026 and earnings guidance for Q2 2026 via press release on May 27, 2026, disclosed under Items 2.02 and 7.01.
View raw filing on EDGAR →Filings Radar
SEC 8-K and 6-K filings classified by Claude with reasoning, plus Form 4 insider transactions. Ingested from EDGAR’s filing stream in near-real time, reconciled overnight.
Showing material events only. Routine administrative filings — bylaw amendments, technical fund updates, procedural FD disclosures — are filtered out so the front page stays signal-dense.
Bath & Body Works, Inc. (BBWI)
Eva C. Boratto, Chief Financial Officer and Chief Accounting Officer, resigned effective June 12, 2026, to pursue another professional opportunity. Tom Javitch was appointed as Interim CFO and D. Andrew Meeting as SVP Controller.
View raw filing on EDGAR →MESA LABORATORIES INC /CO/ (MLAB)
Mesa Laboratories issued a press release on May 27, 2026 disclosing financial results for the three and twelve months ended March 31, 2026, filed under Item 2.02 (Results of Operations and Financial Condition). This is a standard earnings release disclosure with the press release furnished as Exhibit 99.1, which is the typical format for quarterly/annual financial results reporting.
View raw filing on EDGAR →HEALTHCARE SERVICES GROUP INC (HCSG)
This is a classic Item 5.07 disclosure of shareholder meeting results. The filing reports voting outcomes for four proposals: election of nine directors, a say-on-pay advisory vote, ratification of Grant Thornton LLP as independent auditors, and approval of an amendment to the 2020 Omnibus Plan to increase available shares. All proposals passed with majority support. The disclosure is material as it confirms board composition and shareholder approval of executive compensation and equity plan amendments.
View raw filing on EDGAR →ROSS STORES, INC. (ROST)
This is a clear disclosure of shareholder voting results from Ross Stores' Annual Meeting of Stockholders held on May 20, 2026. The filing presents final voting tallies for four proposals: election of 9 directors, approval of the 2026 Equity Incentive Plan, an advisory vote on executive compensation, and ratification of Deloitte & Touche LLP as independent auditor. This is a quintessential Item 5.07 disclosure and directly matches the shareholder_vote_results event type.
View raw filing on EDGAR →NEXTERA ENERGY INC (NEE-PV)
This is a clear disclosure of shareholder voting results from NextEra Energy's 2026 Annual Meeting of Shareholders held on May 21, 2026. The filing reports final voting tallies for five proposals: election of twelve board directors (Proposal 1), ratification of Deloitte & Touche LLP as auditor (Proposal 2), advisory vote on named executive officer compensation (Proposal 3), and two shareholder proposals on climate/Paris Agreement alignment (Proposals 4 and 5). This is a standard Item 5.07 disclosure of annual meeting results, which is material to investors as it reflects shareholder approval of governance and compensation matters.
View raw filing on EDGAR →UNITIL CORP (UTL)
This disclosure concerns Amendment No. 3 to a material acquisition agreement under which Unitil Corporation agreed to acquire all issued and outstanding shares of three water companies (Aquarion Water Company of Massachusetts, Inc., Aquarion Water Company of New Hampshire, Inc., and Abenaki Water Co., Inc.) from Aquarion Water Authority. The amendment extends the termination date from May 25, 2026 to June 30, 2026, representing a modification to an ongoing material acquisition transaction. Item 1.01 explicitly covers entry into material definitive agreements and amendments thereto related to acquisitions.
View raw filing on EDGAR →Sleep Number Corp (SNBR)
Sleep Number held its 2026 Annual Meeting with shareholder voting on seven proposals including director elections, board declassification amendments, auditor ratification, executive compensation advisory vote, and equity plan amendment. The equity plan amendment (increasing reserved shares by 750,000) and auditor ratification passed, while the board declassification and supermajority voting elimination proposals failed to achieve the requisite two-thirds vote.
View raw filing on EDGAR →KEMPER Corp (KMPB)
The filing discloses the appointment of Stephen J. McAnena as President and Chief Executive Officer effective June 1, 2026, and the election of Tony DeSantis as a non-employee director. While the section also includes details on compensatory arrangements and a new Executive Severance Plan, the principal disclosed action centers on these executive and board appointments. The appointment of a new CEO is a material event that would affect a reasonable investor's assessment of the company's leadership and governance.
View raw filing on EDGAR →TRIMBLE INC. (TRMB)
Trimble held its 2026 annual meeting of shareholders on May 26, 2026, with voting results disclosed for four proposals: director elections, say-on-pay advisory vote, auditor ratification, and ESPP amendments. The filing presents complete voting tallies including broker non-votes for each proposal.
View raw filing on EDGAR →TRIMBLE INC. (TRMB)
Thomas Sweet was appointed by the Board as Chair of the Audit Committee, effective May 26, 2026. This appointment is material given its impact on governance and oversight of internal controls, particularly in light of the company's ongoing remediation of material weaknesses in internal control over financial reporting.
View raw filing on EDGAR →ALLSTATE CORP (ALL-PJ)
This is a classic Item 5.07 disclosure reporting the final results of Allstate's annual stockholders meeting held on May 22, 2026. The filing presents voting outcomes for four proposals: election of eleven directors, say-on-pay advisory vote, ratification of Deloitte & Touche LLP as independent auditor, and a shareholder proposal on ESG/DEI metrics in executive compensation. All results are presented with vote counts (For, Against, Abstain, Broker Non-Votes), which is the standard format for shareholder vote result disclosures.
View raw filing on EDGAR →CASELLA WASTE SYSTEMS INC (CWST)
The disclosure announces the pricing and remarketing of $15.0 million in revenue bonds with a new interest rate of 4.300% per annum for a 10-year period (June 1, 2026 to June 1, 2036). While this is a debt refinancing event, it does not fit neatly into the more specific categories (not a covenant breach, not a material impairment, not M&A activity). The mandatory tender and remarketing of existing debt at a new rate is a material financing event that would affect investor assessment of the company's capital structure and debt obligations, warranting disclosure as a material event under Item 8.01.
View raw filing on EDGAR →USCB FINANCIAL HOLDINGS, INC. (USCB)
The filing discloses results of an Annual Meeting of Shareholders held on May 26, 2026, under Item 5.07. The company reports voting results for two proposals: (1) election of nine directors for one-year terms, with detailed vote counts (For, Withheld, Broker Non-votes) for each director nominee, and (2) ratification of Crowe LLP as independent auditor. This is a standard shareholder vote results disclosure that materially informs investors of board composition and auditor approval.
View raw filing on EDGAR →Exeter Select Automobile Receivables Trust 2026-1
EFCAR transferred a substantial portfolio of sub-prime automobile loan receivables (valued at approximately $384.41 million in aggregate note issuance) to a securitization trust structure in exchange for beneficial ownership interests, with secured financing through asset-backed notes issued by the Trust. This constitutes a material disposition of assets and entry into multiple definitive agreements governing the securitization transaction, which is a form of material acquisition/disposition activity reportable under Item 1.01.
View raw filing on EDGAR →TRINET GROUP, INC. (TNET)
This is a clear disclosure of shareholder vote results from TriNet's 2026 Annual Meeting of Stockholders held on May 27, 2026, covering three proposals: election of directors, advisory vote on named executive officer compensation, and ratification of the independent auditor (Deloitte & Touche LLP). The filing presents certified voting tallies for each proposal, which is the quintessential content of Item 5.07 shareholder_vote_results disclosures.
View raw filing on EDGAR →FS Bancorp, Inc. (FSBW)
This is a clear disclosure of shareholder vote results from FS Bancorp's Annual Meeting held May 21, 2026, covering four proposals: election of directors (Terri L. Degner and Michael J. Mansfield), advisory vote on named executive officer compensation, adoption of the 2026 Equity Incentive Plan, and ratification of Baker Tilly US, LLP as independent auditor. All proposals passed with substantial majorities. This is a routine but material Item 5.07 disclosure required by SEC rules.
View raw filing on EDGAR →Orange County Bancorp, Inc. /DE/ (OBT)
This Item 5.07 disclosure reports the final results of Orange County Bancorp's Annual Meeting of Stockholders held on May 26, 2026, including voting outcomes for director elections (Michael J. Gilfeather, Marianna R. Kennedy, and Richard B. Rowley) and ratification of Crowe LLP as independent auditor. All proposals were approved by stockholders, with specific vote tallies provided for each matter.
View raw filing on EDGAR →COMCAST CORP (CCZ)
The filing discloses a press release under Item 8.01 (Other Events) but provides no substantive detail about the press release's content. Without access to Exhibit 99.1, the specific event cannot be determined. Given Comcast's size and the formal 8-K filing, the event is likely material, but the event type cannot be reliably classified into a more specific category.
View raw filing on EDGAR →MOVADO GROUP INC (MOVAA)
Item 2.02 disclosure of first quarter financial results for the period ended April 30, 2026, with a press release attached as Exhibit 99.1. This is a standard earnings release announcement, which is material to investors as it provides periodic financial performance data.
View raw filing on EDGAR →ABERCROMBIE & FITCH CO /DE/ (ANF)
The filing discloses unaudited financial results for Q1 ended May 2, 2026, via a news release attached as Exhibit 99.1. This is a classic earnings release disclosure under Item 2.02, which is material to investors as it provides quarterly operational and financial performance data.
View raw filing on EDGAR →Artificial Intelligence Technology Solutions Inc. (AITX)
The filing discloses conversion of a retail security pilot program into a long-term deployment for AITX's RAD product. While this represents a business development milestone that could be material to investors assessing the company's commercial traction and revenue prospects, the disclosure lacks specific financial metrics, contract terms, or quantified impact. The event does not fit neatly into the more specific taxonomy categories (not an earnings release, M&A activity, or material litigation), making "other_material" the most appropriate classification for this operational/commercial milestone.
View raw filing on EDGAR →Medicus Pharma Ltd. (MDCXW)
Medicus Pharma received written notice from Nasdaq on May 20, 2026, that it failed to meet the minimum Market Value of Listed Securities (MVLS) requirement of $35,000,000 for 30 consecutive business days and does not satisfy alternative listing standards. The company has 180 days until November 16, 2026, to regain compliance or face delisting.
View raw filing on EDGAR →Medicus Pharma Ltd. (MDCXW)
Medicus Pharma entered into a material definitive agreement creating a $22.864 million secured debt financing with embedded equity conversion features, including Note Exchange rights allowing conversion of the B Note into A Notes at a 2-to-1 formula and redemption rights tied to stock price and trading volume. The combination of debt and dilutive equity mechanics creates financial and capital structure implications.
View raw filing on EDGAR →Lightwave Logic, Inc. (LWLG)
This is a clear disclosure of shareholder meeting results under Item 5.07, reporting the outcomes of the 2026 Annual Meeting held on May 21, 2026. The filing presents voting results for two proposals: election of directors (Laila Partridge and Thomas Connelly, Jr.) and ratification of Stephano Slack LLP as independent auditor. These are routine but material governance matters that affect investor understanding of board composition and audit oversight.
View raw filing on EDGAR →DICK'S SPORTING GOODS, INC. (DKS)
Dick's Sporting Goods disclosed quarterly financial results for Q1 fiscal 2026, consistent with the May 27, 2026 filing date and the company's early-February fiscal year-end.
View raw filing on EDGAR →AGILENT TECHNOLOGIES, INC. (A)
Agilent Technologies issued a press release on May 27, 2026 announcing financial results for the second fiscal quarter ended April 30, 2026.
View raw filing on EDGAR →AGILENT TECHNOLOGIES, INC. (A)
Agilent appointed Tim Downs as Vice President, Chief Accounting Officer and principal accounting officer, effective May 20, 2026, following the retirement of Rodney Gonsalves.
View raw filing on EDGAR →SPECTRAL CAPITAL Corp (FCCN)
The Company issued 6,924,700 unregistered shares of common stock as earn-out consideration under a stock purchase agreement, representing approximately 4.7% dilution to outstanding shares. The issuance was made pursuant to Section 4(a)(2) and Regulation D Rule 506(b) exemptions, with recipients holding restrictive legends and lock-up agreements. This is a material dilutive equity issuance properly disclosed under Item 3.02.
View raw filing on EDGAR →Apogee Therapeutics, Inc. (APGE)
Apogee disclosed positive Phase 2 clinical trial results for zumilokibart (APG777) in atopic dermatitis, with the APEX Part B 16-week induction data meeting its primary endpoint (EASI-75) and key secondary endpoints across multiple dose cohorts with statistical significance (p<0.001) and a favorable safety profile, supporting advancement to Phase 3 development.
View raw filing on EDGAR →Apogee Therapeutics, Inc. (APGE)
Apogee entered into a material definitive agreement with Blackstone Life Sciences on May 26, 2026, under which BXLS purchased revenue participation rights in zumilokibart (APG777) in exchange for up to $650 million in staged funding. This material financing and revenue-sharing arrangement affects the company's capital structure and future cash flows.
View raw filing on EDGAR →Translational Development Acquisition Corp. (TDACW)
TDAC entered into an Agreement and Plan of Merger with ProLogium Holding Inc., a SPAC business combination transaction resulting in ProLogium becoming a publicly listed company on Nasdaq under ticker PRLG with an approximately $3.8 billion valuation.
View raw filing on EDGAR →BNB PLUS CORP. (BNBX)
BNB Plus Corp. entered into a Securities Purchase Agreement on May 26, 2026, to issue up to $5 million in convertible preferred equity securities (Series B-1 and Series B-2 Preferred Stock and related Prefunded Warrants) to accredited investors in a private placement, with an initial closing of $2.5 million. The offering includes Warrant Inducement and Exchange Agreements whereby existing investors exercise warrants and exchange common stock and pre-funded warrants for new preferred stock, materially diluting existing shareholders' ownership percentages and voting power.
View raw filing on EDGAR →BNB PLUS CORP. (BNBX)
Item 3.03 discloses a material modification to the rights of security holders in connection with the preferred stock designation and offering structure, incorporating Items 1.01 and 5.03 by reference. The specific nature of the modification to security holder rights cannot be fully determined without access to the complete charter amendments and offering documents.
View raw filing on EDGAR →DigitalBridge Group, Inc. (DBRG-PJ)
DigitalBridge Group entered into an Agreement and Plan of Merger on May 23, 2026, to acquire ArcLight Capital Holdings for $650 million plus contingent earn-out payments. Item 1.01 explicitly discloses "Entry into a Material Definitive Agreement," and the filing details the acquisition structure, purchase price, closing conditions (including regulatory approvals and completion of the SoftBank Transaction), and debt financing commitment. This is a material acquisition transaction that would significantly affect investor assessment of the company's strategic direction and financial position.
View raw filing on EDGAR →PEOPLES FINANCIAL SERVICES CORP. (PFIS)
Peoples Financial Services Corp. held its 2026 annual meeting of shareholders on May 22, 2026, with detailed vote results reported for all five proposals including director elections, advisory compensation vote, frequency of advisory votes, equity plan amendment, and auditor ratification.
View raw filing on EDGAR →Traws Pharma, Inc. (TRAW)
The filing discloses a press release announcing Traws Pharma's antiviral program targeting Hantavirus and Ebola Virus disease outbreaks. This represents a material development in the company's pipeline or strategic focus that would be of interest to investors, but it does not fit neatly into the standard event categories (not an earnings release, M&A activity, executive change, or other defined event type). The disclosure is material because it announces a significant new therapeutic program, but the specific nature of the announcement—a program targeting emerging infectious disease outbreaks—is best classified as other_material.
View raw filing on EDGAR →AMERISERV FINANCIAL INC /PA/ (ASRV)
Mr. Stopko was appointed to a director or officer position. The filing references incorporation by reference to Item 7.01 for substantive disclosure and directs readers to the company's 10-K for details on his role, compensation, and governance status.
View raw filing on EDGAR →MetaVia Inc. (MTVA)
MetaVia disclosed presentation of Phase 1 clinical data for DA-1726, a novel dual OXM analog agonist, at a major medical conference (EASL 2026). For a biopharmaceutical company, positive clinical trial data presentations at peer-reviewed conferences are material events affecting investor assessment of pipeline progress and commercial prospects. However, the disclosure does not fit neatly into the standard taxonomy categories (not earnings, M&A, litigation, impairment, or other defined event types), warranting classification as other_material.
View raw filing on EDGAR →CNH Equipment Trust 2026-B
CNH Capital Receivables LLC disclosed entry into material definitive agreements on May 27, 2026, related to the public issuance of approximately $907.68 million in asset-backed notes by CNH Equipment Trust 2026-B across four classes (A-1, A-2a, A-2b, A-3, and A-4). While this is a securitization/financing transaction rather than a traditional M&A activity, it represents a material capital markets transaction that would affect investor assessment of the registrant's financing structure and liquidity. The classification as "ma_activity" is the closest fit under the available taxonomy, though this is more precisely a material financing/securitization event.
View raw filing on EDGAR →KROGER CO (KR)
Timothy A. Massa, Executive Vice President and Associate Experience Officer, provided notice of his intention to retire in fall 2026, with his active role ending in September 2026. This is a clear departure of a named executive officer at a major public company. While the transition is orderly and phased through July 2027, the principal disclosed action is the executive's departure from his operational role, making this an exec_departure event that would be material to investors assessing leadership continuity.
View raw filing on EDGAR →B&G Foods, Inc. (BGS)
This Item 5.07 disclosure reports the results of B&G Foods' annual meeting of stockholders held on May 21, 2026, including voting outcomes for three proposals: election of ten directors, advisory approval of named executive officer compensation, and ratification of KPMG LLP as independent auditor. The detailed vote tallies (For, Against, Abstain, Broker Non-Votes) for each director nominee and proposal are the hallmark of shareholder vote results disclosures.
View raw filing on EDGAR →MOLSON COORS BEVERAGE CO (TAP-A)
Molson Coors issued $1.5 billion in U.S. senior notes and C$500 million in Canadian senior notes on May 27, 2026, pursuant to supplemental indenture agreements, creating approximately $1.846 billion in aggregate direct financial obligations. The offering consisted of 2031 and 2036 U.S. notes at 4.900% and 5.500% rates, plus Canadian notes at 4.300%, representing a material debt financing transaction affecting the company's capital structure and liquidity.
View raw filing on EDGAR →Passage BIO, Inc. (PASG)
The filing discloses termination of two material definitive agreements: (1) the Gemma Collaboration Agreement involving research and license rights for Huntington's disease and Temporal Lobe Epilepsy programs, and (2) the 2005 Market Street Lease Agreement with a $2.3 million termination fee. While Item 1.02 is titled "Termination of a Material Definitive Agreement," neither termination fits cleanly into the specific event taxonomy (not M&A, not covenant breach, not litigation). The Gemma termination is particularly material as it affects active R&D programs in CNS indications, and the lease termination involves a significant cash outlay. This is best classified as other_material given the absence of a more specific category for strategic collaboration or lease terminations.
View raw filing on EDGAR →LTC PROPERTIES INC (LTC)
This is a clear disclosure of shareholder vote results from LTC's 2026 Annual Meeting of Stockholders held on May 20, 2026. The filing reports voting outcomes for three proposals: election of six directors, advisory approval of executive compensation, and ratification of Ernst & Young LLP as independent auditor. This is a standard Item 5.07 disclosure that is material to investors as it documents the results of fundamental corporate governance matters.
View raw filing on EDGAR →Citi Trends Inc (CTRN)
Item 2.02 discloses a press release issued on May 27, 2026 providing preliminary financial results for the first quarter ended May 2, 2026. This is a classic earnings release disclosure, with the press release attached as Exhibit 99.1. Quarterly financial results are material to investors' assessment of the registrant's performance and financial condition.
View raw filing on EDGAR →TTEC Holdings, Inc. (TTEC)
TTEC Holdings held its 2026 Annual Meeting of Stockholders on May 21, 2026, with voting results on four proposals: election of seven directors, ratification of PricewaterhouseCoopers LLP as independent auditor, advisory approval of named executive officer compensation, and approval of re-domestication from Delaware to Texas.
View raw filing on EDGAR →TTEC Holdings, Inc. (TTEC)
TTEC Holdings completed a re-domestication from Delaware to Texas on May 22, 2026, changing its state of incorporation and governing law. The company disclosed that the re-domestication did not materially affect business operations, assets, liabilities, or material contracts.
View raw filing on EDGAR →Liminatus Pharma, Inc. (LIMNW)
Liminatus Pharma received notice from Nasdaq on May 20, 2026 that it failed to regain compliance with the MVLS Rule and MVPHS Rule by the May 18, 2026 deadline, resulting in delisting from The Nasdaq Global Market effective May 29, 2026 unless an appeal is granted. The company requested an appeal on May 26, 2026, which stays the delisting pending a hearing. This is a clear delisting notice under Item 3.01.
View raw filing on EDGAR →GOLUB CAPITAL BDC, Inc. (GBDC)
On May 27, 2026, the Company entered into a Sixth Supplemental Indenture governing the issuance and sale of $500.0 million in aggregate principal amount of 6.250% Notes due 2031. The proceeds are intended to repay existing indebtedness and fund general corporate purposes including portfolio investments.
View raw filing on EDGAR →